MWM
IRWD icon

Moran Wealth Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Moran Wealth Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200,160
Closed -$2.29M – 431
2023
Q4 		$2.29M Sell
200,160
-2,230
-1% -$22.1K 0.08% 242
2023
Q3 		$1.95M Buy
202,390
+5,259
+3% +$51.5K 0.08% 216
2023
Q2 		$2.1M Buy
197,131
+7,543
+4% +$81.1K 0.08% 224
2023
Q1 		$1.99M Buy
189,588
+37,994
+25% +$426K 0.08% 221
2022
Q4 		$1.88M Buy
+151,594
New +$1.72M 0.07% 217

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Moran Wealth Management's IRWD Position: Q1 2024 in Review

Moran Wealth Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2024, closing a stake of 200,160 shares — an estimated $2.29M sold.

Moran Wealth Management first reported a position in IRWD in Q4 2022 and held it in 5 quarters. The position peaked at $2.29M in Q4 2023. 261 funds tracked by Wall St. Rank hold IRWD as of Q1 2024.

  • Moran Wealth Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Moran Wealth Management sold 200,160 Ironwood Pharmaceuticals shares in Q1 2024, an estimated $2.29M.
  • Moran Wealth Management first reported a position in Ironwood Pharmaceuticals in Q4 2022 and held it in 5 quarters.
  • Moran Wealth Management's Ironwood Pharmaceuticals position peaked at $2.29M in Q4 2023.
  • 261 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2024.

Based on Moran Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.